This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Byung Hoi Lee: Innovator in Pharmaceutical Chemistry
Introduction
Byung Hoi Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing autophagy-related diseases, which are critical in the context of modern healthcare.
Latest Patents
Byung Hoi Lee holds a patent for an isoquinoline derivative, which includes a preparing method and a pharmaceutical composition aimed at preventing or treating autophagy-related diseases. This innovative compound is designed to regulate autophagy activity, offering potential therapeutic benefits for conditions such as neurodegenerative diseases, cancer, metabolic disorders, inflammatory diseases, and issues related to melanogenesis. The patent highlights the versatility of the isoquinoline furanone derivative, which can also be utilized in health functional food compositions and cosmetic products with whitening functions.
Career Highlights
Lee is affiliated with the Korea Research Institute of Chemical Technology, where he conducts research and development in chemical technology. His expertise in pharmaceutical chemistry has positioned him as a key figure in the advancement of treatments for complex diseases. His work is characterized by a commitment to innovation and the application of scientific research to real-world health challenges.
Collaborations
Some of his notable coworkers include Myung-Ae Bae and Dae-Seop Shin. Their collaborative efforts contribute to the ongoing research and development initiatives at the Korea Research Institute of Chemical Technology.
Conclusion
Byung Hoi Lee's contributions to pharmaceutical chemistry, particularly through his patented isoquinoline derivative, demonstrate his commitment to advancing medical science. His work has the potential to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile